Bacterial pneumonia in HIV-infected patients: Use of the pneumonia severity index and impact of current management on incidence, aetiology and outcome

HIV Medicine

Volumn 9, Issue 8, 2008, Pages 609-615

  Curran, Adrian ^a   Falco V ^a   Crespo, M ^a   Martinez, X ^a   Ribera, E ^a   Villar Del Saz, S ^a   Imaz, A ^a   Coma, E ^a   Ferrer, A ^a   Pahissa, A ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Bacterial pneumonia; HAART; HIV infection; Pneumococcal vaccine; Pneumonia severity index

Indexed keywords

ANTIBIOTIC AGENT; ANTIRETROVIRUS AGENT; COTRIMOXAZOLE; PNEUMOCOCCUS VACCINE; STEROID;

ADULT; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTERIAL PNEUMONIA; BACTERIUM ISOLATION; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOSPITAL PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RATE; INFECTION RISK; INTRAVENOUS DRUG ABUSE; LEGIONELLA PNEUMOPHILA; MAJOR CLINICAL STUDY; MALE; MORTALITY; NONHUMAN; OBSERVATIONAL STUDY; PNEUMONIA SEVERITY INDEX; PRIORITY JOURNAL; PROGNOSIS; SPAIN; STREPTOCOCCUS PNEUMONIAE; TERTIARY HEALTH CARE; VACCINATION; VIRUS LOAD;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; FEMALE; HEALTH STATUS INDICATORS; HIV INFECTIONS; HIV-1; HUMANS; INCIDENCE; LEGIONELLA PNEUMOPHILA; LEGIONNAIRES' DISEASE; MALE; MIDDLE AGED; PNEUMONIA, BACTERIAL; PNEUMONIA, PNEUMOCOCCAL; REGRESSION ANALYSIS; RISK FACTORS; SPAIN; SUBSTANCE ABUSE, INTRAVENOUS; TREATMENT OUTCOME;

EID: 52649165176     PISSN: 14642662     EISSN: 14681293     Source Type: Journal    
DOI: 10.1111/j.1468-1293.2008.00603.x     Document Type: Article

References (29)

1. Dufour V, Cadranel J, Wislez M et al. Changes in the pattern of respiratory diseases necessitating hospitalization of HIV-infected patients since the advent of highly active antiretroviral therapy. Lung 2004; 182: 331-341.
2. Wolff AJ, O'Donnell AE. Pulmonary manifestations of HIV infection in the era of highly active antiretroviral therapy. Chest 2001; 120: 1888-1893.
3. Grubb J, Moorman A, Baker R, Masur H and the HOPS investigators. The changing spectrum of pulmonary disease in patients with HIV infection on antiretroviral therapy. AIDS 2006; 20: 1095-1107.
4. Hirschtick RE, Glassroth J, Jordan MC et al. Bacterial pneumonia in persons infected with the human immunodeficiency virus. N Engl J Med 1995; 333: 845-851.
5. Kohli R, Lo Y, Homel P et al. Bacterial pneumonia, HIV therapy, and disease progression among HIV-infected women in the HIV epidemiologic research (HER) study. Clin Infect Dis 2006; 43: 90-98.
6. Afesa B, Green B. Bacterial pneumonia in hospitalized patients with HIV infection. Chest 2000; 117: 1017-1022.
7. Falcó V, Fernandez de Sevilla T, Alegre J et al. Bacterial pneumonia in HIV-infected patients: A prospective study of 68 episodes. Eur Respir J 1994; 7: 235-239.
8. Park DR, Sherbin VL, Goodman MS et al. The aetiology of community-acquired pneumonia at an urban public hospital: Influence of human immunodeficiency virus infection and initial severity of illness. J Infect Dis 2001; 184: 268-277.
9. Heffernan RT, Barrett NL, Gallagher KM et al. Declining incidence of invasive Streptococcus pneumoniae infections among persons with AIDS in era of highly active antiretroviral therapy, 1995-2000. J Infect Dis 2005; 191: 2038-2045.
10. Grau I, Pallares R, Tubau F et al. Epidemiologic changes in bacteremic pneumococcal disease in patients with Human Immunodeficiency Virus in the era of highly active antiretroviral therapy. Arch Intern Med 2005; 165: 1533-1540.
11. Benito N, Rañó A, Moreno A et al. Pulmonary infiltrates in HIV-infected patients in the Highly Active Antiretroviral Therapy era in Spain. J Acquir Immune Defic Syndr 2001; 27: 35-43.
12. Feikin D, Feldman C, Schuchat A et al. Global strategies to prevent bacterial pneumonia in adults with HIV disease. Lancet Infect Dis 2004; 4: 445-455.
13. Nuorti JP, Butler JC, Gelling L et al. Epidemiologic relation between HIV and invasive pneumococcal disease in San Francisco County, California. Ann Intern Med 2000; 132: 182-190.
14. Jordano Q, Falcó V, Almirante B et al. Invasive pneumococcal disease in HIV-infected patients: Still a threat in the era of highly active antiretroviral therapy. Clin Infect Dis 2004; 38: 1623-1628.
15. Navin TR, Rimland D, Lennox JL et al. Risk factors for community-acquired pneumonia among persons infected with human immunodeficiency virus. J Infect Dis 2000; 181: 158-164.
16. Eigenmann C, Flepp M, Bernasconi E et al. Low incidence of community-acquired pneumonia among human immunodeficiency virus-infected patients after interruption of Pneumocystis carinii pneumonia prophylaxis. Clin Infect Dis 2003; 36: 917-921.
17. Paul S, Gilbert HM, Lande L et al. Impact of antiretroviral therapy on decreasing hospitalization rates of HIV-infected patients in 2001. AIDS Res Hum Retroviruses 2002; 18: 501-506.
18. Lopez-Palomo C, Martin-Zamorano M, Benitez E et al. Pneumonia in HIV-infected patients in the HAART era: Incidence, risk, and impact of the pneumococcal vaccination. J Med Virol 2004; 72: 517-524.
19. de Gaetano K, Tumbarello M, Tacconelli E et al. Impact of highly active antiretroviral therapy (HAART) on the incidence of bacterial infections in HIV-infected subjects. J Chemother 2003; 15: 60-65.
20. Barry PM, Zetola N, Keruly JC et al. Invasive pneumococcal disease in a cohort of HIV-infected adults: Incidence and risk factors, 1990-2003. AIDS 2006; 20: 437-444.
21. Pierce AB, Hoy JF. Is the recommendation for pneumococcal vaccination of HIV patients evidence based? J Clin Virol 2001; 22: 255-261.
22. Peñaranda M, Falco V, Payeras A et al. Effectiveness of polysaccharide pneumococcal vaccine in HIV-infected patients: A case-control study. Clin Infect Dis 2007; 45: E82-e87.
23. Sanders KM, Marras TK, Chan CK. Pneumonia severity index in the immunocompromised. Can Respir J 2006; 13: 89-93.
24. Fine MJ, Auble TE, Yealy DM et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997; 336: 243-250.
25. Rodriguez-Barradas MC, Musher DM, Lahart C et al. Antibody to capsular polysaccharides of Streptococcus pneumoniae after vaccination of human immunodeficiency virus-infected subjects with 23-valent pneumococcal vaccine. J Infect Dis 1992; 165: 553-556.
26. Loeliger AE, Rijkers GT, Aerts P et al. Deficient antipneumococcal polysaccharide responses in HIV-seropositive patients. FEMS Immunol Med Microbiol 1995; 12: 33-41.
27. Fichtenbaum CJ, Woeltje KF, Powderly WG. Serious Pseudomonas aeruginosa infections in patients infected with human immunodeficiency virus: A case-control study. Clin Infect Dis 1994; 19: 417-422.
28. Schuster MG, Norris AH. Community-acquired Pseudomonas aeruginosa pneumonia in patients with HIV infection. AIDS 1994; 8: 1437-1441.
29. Christensen D, Feldman C, Rossi P et al. HIV infection does not influence clinical outcomes in hospitalized patients with bacterial community-acquired pneumonia: Results from the CAPO international cohort study. Clin Infect Dis 2005; 41: 554-556.